Fatma Aksakal
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Fatma Aksakal has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Burcu Kilic
Gazi Üniversitesi
3 shared publications - Deniz Songul Dogruer
Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Gazi University, Ankara, Turkey
2 shared publications - Rahsan Ilikci Sagkan
Department of Medical Biology, Faculty of Medicine, Usak University, Uşak, Turkey
2 shared publications - Shakila Shakila
Gazi Univ, Fac Pharm, Dept Pharmaceut Chem, Ankara, Turkiye
2 shared publications Deniz S. Dogruer
1 shared publicationMerve Bardakkaya
Department of Pharmaceutical Chemistry, Faculty of Pharmacy Gazi University Ankara Turkiye
1 shared publication
Latest Publications
- 15 April 2026
- Published by Elsevier in Journal of Molecular Structure
- Vol. 1368
Synthesis, biological evaluation, and computational analysis of chromone-based carboxamides targeting Alzheimer’s disease
- 15 April 2026
- Published by Elsevier in Journal of Molecular Structure
- Vol. 1368
Synthesis, biological evaluation, and computational analysis of chromone-based carboxamides targeting Alzheimer’s disease
- Open Access
- 5 June 2023
- Published by Wiley in Archiv der Pharmazie
- Vol. 356 (8) , e2300054
Synthesis and evaluation of multitarget new 2‐aminothiazole derivatives as potential anti‐Alzheimer's agents
In this study, two diverse series of 2‐aminothiazole‐based multitarget compounds, one propenamide and the other propanamide derivatives, were designed and synthesized. Subsequently, their anticholinesterease and antioxidant (ORAC) activities were tested. Among them, compound 3e was the most potent acetylcholinesterase (AChE) inhibitor (AChE IC50 = 0.5 μM, butyrylcholinesterase [BChE] IC50 = 14.7 μM) and compound 9e was the most potent BChE inhibitor (AChE IC50 = 3.13 μM, BChE IC50 = 0.9 μM). Kinetic experiments showed that both compounds were mixed‐type inhibitors. According to the anticholinesterease activity results, five compounds (3e, 4e, 5e, 9d, and 9e) were selected for further activity studies, all of which are dual cholinesterase inhibitors. Then, selected compounds were investigated in terms of their metal chelation activity. Moreover, their neuroprotective effects against H2O2‐induced damage in the PC12 cell line were evaluated at 10 μM and the results showed that the neuroprotective effect of 3e was 53% compared with the reference ferulic acid (77%). 3‐(4,5‐dimethylthiazol‐2‐yl)‐2,5‐diphenyltetrazolium bromide (MTT) results of selected compounds revealed that the compounds were noncytotoxic. Additionally, 3e was more effective in reducing lipopolysaccharides‐induced interleukin‐1β (IL‐1β), IL‐6, tumor necrosis factor‐α (TNF‐α), and nitric oxide (NO) production in the human monocyte derived from patient with acute monocytic leukemia cell line compared with other selected compounds. Finally, a molecular docking study was also performed.
- 5 June 2023
- Published by Wiley in Archiv der Pharmazie
- Vol. 356 (8) , e2300054
Open AccessSynthesis and evaluation of multitarget new 2‐aminothiazole derivatives as potential anti‐Alzheimer's agents
In this study, two diverse series of 2‐aminothiazole‐based multitarget compounds, one propenamide and the other propanamide derivatives, were designed and synthesized. Subsequently, their anticholinesterease and antioxidant (ORAC) activities were tested. Among them, compound 3e was the most potent acetylcholinesterase (AChE) inhibitor (AChE IC50 = 0.5 μM, butyrylcholinesterase [BChE] IC50 = 14.7 μM) and compound 9e was the most potent BChE inhibitor (AChE IC50 = 3.13 μM, BChE IC50 = 0.9 μM). Kinetic experiments showed that both compounds were mixed‐type inhibitors. According to the anticholinesterease activity results, five compounds (3e, 4e, 5e, 9d, and 9e) were selected for further activity studies, all of which are dual cholinesterase inhibitors. Then, selected compounds were investigated in terms of their metal chelation activity. Moreover, their neuroprotective effects against H2O2‐induced damage in the PC12 cell line were evaluated at 10 μM and the results showed that the neuroprotective effect of 3e was 53% compared with the reference ferulic acid (77%). 3‐(4,5‐dimethylthiazol‐2‐yl)‐2,5‐diphenyltetrazolium bromide (MTT) results of selected compounds revealed that the compounds were noncytotoxic. Additionally, 3e was more effective in reducing lipopolysaccharides‐induced interleukin‐1β (IL‐1β), IL‐6, tumor necrosis factor‐α (TNF‐α), and nitric oxide (NO) production in the human monocyte derived from patient with acute monocytic leukemia cell line compared with other selected compounds. Finally, a molecular docking study was also performed.
- 28 February 2023
- Published by Kocaeli University in Acta Medica Nicomedia
- Vol. 6 (1) , 82-91
Antitüberküloz Triptantrin analoglarının elektronik ve topolojik özelliklerinin ve enoil-ACP redüktaz ile etkileşimlerinin in silico yöntemlerle incelenmesi
- 28 February 2023
- Published by Kocaeli University in Acta Medica Nicomedia
- Vol. 6 (1) , 82-91
Antitüberküloz Triptantrin analoglarının elektronik ve topolojik özelliklerinin ve enoil-ACP redüktaz ile etkileşimlerinin in silico yöntemlerle incelenmesi